International Journal of Drug Delivery Technology
Volume 14, Issue 1

Promising Antidiabetic Effects of Pomegranate Fruit Parts

More RK1*, Pingale PL2, Upasani CD3

1SNJB’S Shriman Sureshdada Jain Collage of Pharmacy, Chandwad, Nashik, Maharashtra, India

2MS Gosavi Collage of Pharmaceutical Education and Research, Nashik, Maharashtra, India

3Shriman Sureshdada Jain College of Pharmacy, Neminagar, Chandwad, Maharashtra, India

Received: 02nd November, 2023; Revised: 10th January, 2024; Accepted: 10th February, 2024; Available Online: 25th March, 2024

ABSTRACT

Diabetes is a physiological illness that develops as because of decreased insulin secretion and/or its and /or how it functions within the body. Food metabolism becomes altered as a result of low or inactive insulin. As the illness worsens, the body begins to experience pathological alterations such as nephropathy, retinopathy, and cardiovascular problems. Diabetes mellitus is treated through oral hypoglycemic agents, which are synthetic drugs. As there are many side effects are associated with a longer duration of treatment of synthetic drugs, there is need to develop herbal medicine. There is much evidence that almost all parts of the pomegranate fruit help avoid and control numerous illnesses and conditions, such as diabetes. This review highlights the pathophysiological conditions of diabetes and also summarizes many laboratory and clinical studies of pomegranates that have examined the pomegranates its elements with regard to physiological and biochemical events of diabetes and related considerations.

Keywords: Diabetes mellitus and its types, Peel extract, Arils extract, Flowers extract, Punicalgin. International Journal of Drug Delivery Technology (2024); DOI: 10.25258/ijddt.14.1.82

How to cite this article: More RK, Pingale PL, Upasani CD. Promising Antidiabetic Effects of Pomegranate Fruit Parts. International Journal of Drug Delivery Technology. 2024;14(1):609-614.

REFERENCES

  1. American Diabetes Diagnosis and classification of diabetes mellitus. Diabetes Care. 2010 Jan; 33(1):S62-69.
  2. Papatheodorou K, Banach M, Bekiari E, Rizzo M, Edmonds Complications of Diabetes 2017. J Diabetes Res. 2018. (Vol.2018):1-4.
  3. Forouhi NG, Wareham Epidemiology of diabetes. Medicine (Abingdon). 2014 Dec;42(12):698-702.
  4. Kumar PJ, Clark M. Textbook of Clinical Medicine. Saunders, (London, UK ed.). 2002. (8), 1099-1121.
  5. Baynest, HW. Classification, Pathophysiology, Diagnosis and Management of Diabetes Mellitus. Journal of diabetes & metabolism. 2015; 6:1-9.
  6. Verma SM, Gupta P, Harvinder, Aggarwal Diabetes mellitus treatment using herbal drugs. International Journal of Phytomedicine. 2018;10(1):1-10.
  7. McIntyre HD, Catalano P, Zhang C, Desoye G, Mathiesen ER, Damm P. Gestational diabetes mellitus. Nat Rev Dis Primers. 2019;5(1):47.
  8. Abhinav M, Neha J, Anne G, Bharti V. Role of novel drug delivery systems in bioavailability enhancement: At a glance. International Journal of Drug Delivery Technology. 2016;6 (1):7-26.
  9. Suttee A, Singh G, Yadav N, Pratap Barnwal R, Singla N, Prabhu KS, Mishra V. A review on status of nanotechnology in pharmaceutical Int. J. Drug Deliv. Technol. 2019;9:98- 103.
  10. Jasim TM, Latif AA, Redah The effect of Silver Nanoparticle Induced Diabetic on Wound Healing Full Thickness Pseudomonas aeruginosa Contaminated Mouse Skin Wound Models. International Journal of Pharmaceutical Quality Assurance. 2019; 10(4): 720-724.
  11. Guthrie RA, Guthrie Pathophysiology of diabetes mellitus. Critical care nursing quarterly. 2004; 27(2):113–125.
  12. Sherwin R, Felig P. Pathophysiology of Diabetes Mellitus. Medical Clinics of North America. 1978; 62(4): 695-711.
  13. Masur K, Thévenod F, Zanker Pathophysiology of Diabetes Mellitus Type 2: Roles of Obesity, Insulin Resistance and β-cell Dysfunction. Diabetes and Cancer. Epidemiological Evidence and Molecular Links. Front Diabetes. 2008; (19): 1–18.
  14. Ahmed A. History of Diabetes Mellitus. Saudi medical journal. 2019;23: 375-378.
  15. Holt RI. Diagnosis, epidemiology and pathogenesis of diabetes mellitus: an update for psychiatrists. The British journal of psychiatry. Suppl. 2004;47: 55–63.
  16. So WY, Ng MC, Lee SC, Sanke T, Lee HK, Chan JC. Genetics of type 2 diabetes Hong Kong Med J. 2000;6(1):69-76.
  17. Reddy VJ, Sahay R, Bhadada SK, Agrawal JK, Agrawal Newer Oral Antidiabetic Agents. 2003
  18. Shishehbor F, Mohammad Shahi M, Zarei M, Saki A, Zakerkish M, Shirani F, Zare . Effects of Concentrated Pomegranate Juice on Subclinical Inflammation and Cardiometabolic Risk Factors for Type 2 Diabetes: A Quasi-Experimental Study. International journal of endocrinology and metabolism. 2016;14(1): 1-7.
  19. Tenenbaum A, Motro M, Fisman Dual and pan-peroxisome proliferator-activated receptors (PPAR) co-agonism: the bezafibrate lessons. Cardiovasc Diabetol 2005;4(14): 1-5.
  20. Bhowmik D, Gopinath H, Kumar BP, Duraivel S, Aravind G, Sampath Kumar Medicinal Uses of Punica granatum and Its Health Benefits. Journal of Pharmacognosy and Phytochemistry. 2013;1(5): 28-35.
  21. Fateh MV, Ahmed S, Mohammed A, Bandyopadhyay S. A Review on the Medicinal Importance of Pomegranate. Rajiv Gandhi University of Health Sciences Journal of Pharmaceutical Sciences.2013;3: 23-25.
  22. Rahimi HR, Arastoo M, Ostad SN. A Comprehensive Review of Punica granatum (Pomegranate) Properties in Toxicological, Pharmacological, Cellular and Molecular Biology Researches. Iranian journal of pharmaceutical 2012; 11(2): 385–400.
  23. Tezcan F, Gultekin-Ozguven M, Diken T, Ozcelik B, Erim FB. Antioxidant Activity and Total Phenolic, Organic Acid and Sugar Content in Commercial Pomegranate Juices. Food Chemistry 2009; 115(3):873-877.
  24. Verardo V, Patricia S, Baldi E, Carretero AG, Fernandez AG, Caboni MF. Pomegranate seeds as a source of nutraceutical oil naturally rich in bioactive lipids. Food Research International. 2014; 65: 445-452.
  25. Khan NH, Ying ALT, Tian Screening of Punica Granatum seeds for antibacterial and antioxidant activity with various extracts. J Gastroenterol Dig Dis. 2017;1(1):1-7.
  26. Parmar HS, Kar A. Antidiabetic potential of Citrus sinensis and Punica granatum peel extracts in alloxan treated male mice. Biofactors. 2007;31:17-24.
  27. Parmar HS, Kar A. Medicinal values of fruit peel from Citrus sinensis, Punica granatum, and Musa paradisiaca with respect to alterations in tissue lipid peroxidation and serum concentration of glucose, insulin, and thyroid hormones. J. Med. Food. 2006; 11:376-381.
  28. Redha A, Hasan and Mandeel Q. Phytochemical Determinations of Pomegranate (Punica granatum) Rind and Aril Extracts and their Antioxidant, Antidiabetic and Antibacterial Activity. Natural Products Chemistry & Research. 2018; 06(4): 1-9.
  29. Singh RP, Chidambara Murthy KN, Jayaprakasha GK. Studies on the antioxidant activity of pomegranate (Punica granatum) peel and seed extracts using in vitro J Agric Food Chem. 2002; 50(1):81-6.
  30. Li Y, Guo C, Yang J, Wei J, Xu J, Cheng S. Evaluation of antioxidant properties of pomegranate pulp extract. Food Chemistry. 2006; 96: 254-260.
  31. Arun K, Jayamurthy P, Anusha CV, Mahesh SK, Nisha Studies on Activity Guided Fractionation of Pomegranate Peel Extracts and Its Effect on Antidiabetic and Cardiovascular Protection Properties. Journal of Food Processing and Preservation. 2017; 41(1):1-12.
  32. Khalil Antidiabetic effect of an aqueous extract of Pomegranate (Punica granatum L.) peels in normal and alloxan diabetic rats. The Egyptian Journal of Hospital Medicine. 2004; 16(1): 92-99.
  33. Rozenberg O, Howell A, Aviram M. Pomegranate juice sugar fraction reduces macrophage oxidative state, whereas white grape juice sugar fraction increases it. Atherosclerosis. 2006; 188(1): 68–76.
  34. Banihani S, Swedan S, Alguraan Pomegranate and type 2 diabetes. Nutrition Research. 2013; 33(5):341-34.
  35. Das AK, Mandal SC, Banerjee SK, Sinha S, Saha BP, Pal M. Studies on the hypoglycaemic activity of Punica granatum seed in streptozotocin induced diabetic rats. Phytother. Res. 2001; 15:628-629.
  36. Jafri MA, Aslam M, Javed K, Singh Effect of Punica granatum Linn. (flowers) on blood glucose level in normal and alloxan- induced diabetic rats. Journal of ethnopharmacology. 2000; 70(3): 309–314.
  37. Li Y, Qi Y, Huang TH, Yamahara J, Roufogalis BD Pomegranate flower: a unique traditional antidiabetic medicine with dual PPAR-α/-γ activator Diabetes, obesity & metabolism. 2008; 10(1): 10–17.
  38. Al-Muammar M N, Khan Obesity: the preventive role of the pomegranate (Punica granatum). Nutrition. 2012; 28(6): 595–604.
  39. Al-Zoreky Antimicrobial activity of pomegranate (Punica granatum L.) fruit peels. International journal of food microbiology. 2009; 134(3): 244–248.
  40. Sreekumar S, Sithul H, Muraleedharan P, Azeez JM, Sreeharshan Pomegranate fruit as a rich source of biologically active compounds. BioMed research international. 2014; 1-12.
  41. Medjakovic S, Jungbauer Pomegranate: a fruit that ameliorates metabolic syndrome. Food & function. 2013; 4(1): 19–39.
  42. Katz SR, Newman RA, Lansky EP. Punica granatum: heuristic treatment for diabetes Journal of medicinal food. 2007; 10(2): 213–217.